Mier, Myrien Glie T.

HRN: 21-55-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
CEFUROXIME 750MG (VIAL)
06/26/2022
07/02/2022
IVTT
750mg
Q8
S/P Repeat LTCS
06/27/2022
CEFUROXIME 500MG (TAB)
06/27/2022
07/03/2022
ORAL
500mg
BID
S/P LTCS
Waiting Final Action 
06/27/2022
CEFUROXIME 500MG (TAB)
06/27/2022
07/04/2022
ORAL
500mg/tab
BID
S/P Repeat LSTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: